You have no items in your shopping cart.
Imperialine 3-β-D-glucoside
SKU: orb1297207
Description
Images & Validation
−
Key Properties
−| CAS Number | 67968-40-5 |
|---|---|
| MW | 591.78 |
| Purity | 99.90% (May vary between batches) |
| Formula | C33H53NO8 |
| SMILES | [H][C@@]12C[C@@]3([H])[C@@]([H])(CC(=O)[C@@]4([H])C[C@H](CC[C@]34C)O[C@]3([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@]1([H])CC[C@]1([H])[C@@]2([H])CN2C[C@@H](C)CC[C@@]2([H])[C@@]1(C)O |
| Target | Others |
| Solubility | 10% DMSO+40% PEG300+5% Tween-80+45% Saline:1 mg/mL (1.69 mM);DMSO:30 mg/mL (50.69 mM) |
Storage & Handling
−| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−inhibit, Imperialine 3 β D glucoside, Imperialine 3-b-D-glucoside, Imperialine 3-beta-D-glucoside, Imperialine 3βDglucoside, Imperialine 3-β-D-glucoside, Inhibitor, Sipeimine-3-β-D-glucoside, Sipeimine-3-b-D-glucoside, Sipeimine-3-beta-D-glucoside
Similar Products
−Imperialine 3-β-D-glucoside [orb1217739]
>98% (HPLC)
67968-40-5
591.8
C33H53NO8
1 g, 500 mg, 200 mg, 50 mg, 5 mg, 10 mg, 25 mg, 100 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Compound Identifiers
PubChem CID
Key Properties
− No computed properties available.
Documents Download
Datasheet
Product Information
Request a Document
Protocol Information
Imperialine 3-β-D-glucoside (orb1297207)
Based on 0 reviews
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review